Holen Sie sich die Stockscreener-App
29.29
1.05%
-0.31
Handel nachbörslich:
29.29
Schlusskurs vom Vortag:
$29.60
Offen:
$29.63
24-Stunden-Volumen:
555.33K
Relative Volume:
0.87
Marktkapitalisierung:
$1.18B
Einnahmen:
$128.29M
Nettoeinkommen (Verlust:
$-30.69M
KGV:
-35.72
EPS:
-0.82
Netto-Cashflow:
$-27.17M
1W Leistung:
-1.74%
1M Leistung:
-9.82%
6M Leistung:
-48.11%
1J Leistung:
-46.44%
1-Tages-Spanne:
$29.07
$29.79
1-Wochen-Bereich:
$29.07
$31.79
52-Wochen-Spanne:
$26.29
$66.54
Rxsight Inc Stock (RXST) Company Profile
Firmenname
Rxsight Inc
Sektor
Branche
Telefon
949-521-7822
Adresse
100 COLUMBIA STREET, ALISO VIEJO
Vergleichen Sie RXST mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RXST
Rxsight Inc
|
29.29 | 1.18B | 128.29M | -30.69M | -27.17M | -0.82 |
|
ABT
Abbott Laboratories
|
134.95 | 234.06B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
104.39 | 154.06B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
387.92 | 148.02B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
90.17 | 115.71B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
72.76 | 42.91B | 5.72B | 4.17B | 490.10M | 6.97 |
Rxsight Inc Stock (RXST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-20 | Herabstufung | Stifel | Buy → Hold |
| 2024-12-11 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | Eingeleitet | UBS | Buy |
| 2024-10-29 | Eingeleitet | Jefferies | Buy |
| 2024-08-20 | Bestätigt | Needham | Buy |
| 2024-08-06 | Bestätigt | Needham | Buy |
| 2024-05-07 | Bestätigt | BTIG Research | Buy |
| 2023-12-13 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-12-12 | Eingeleitet | Stifel | Buy |
| 2023-12-04 | Eingeleitet | Morgan Stanley | Overweight |
| 2023-04-13 | Eingeleitet | Oppenheimer | Outperform |
| 2022-12-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-08 | Eingeleitet | Needham | Buy |
Alle ansehen
Rxsight Inc Aktie (RXST) Neueste Nachrichten
Van ECK Associates Corp Has $112,000 Stock Position in RxSight, Inc. (NASDAQ:RXST) - Defense World
When (RXST) Moves Investors should Listen - Stock Traders Daily
Stifel maintains hold on RxSight shares, target at $35.00 - Investing.com
Stifel maintains hold on RxSight shares, target at $35.00 By Investing.com - Investing.com South Africa
Stifel Reiterates Hold Rating on RxSight Inc. (RXST) - StreetInsider.com
RxSight (NASDAQ:RXST) Trading Down 4.7%Should You Sell? - MarketBeat
Midday Stock Roundup: RxSight Down 6.1% on Weak Post-3Q Results - Orange County Business Journal
Analysts Set RxSight, Inc. (NASDAQ:RXST) Price Target at $58.13 - MarketBeat
RxSight, Inc. (NASDAQ:RXST) Receives $58.13 Consensus Price Target from Analysts - Defense World
RxSight, Inc. to Report Fourth Quarter Financial Results on February 25, 2025 - GlobeNewswire
RxSight, Inc. to Report Fourth Quarter 2024 Financial Results on February 25, 2025 - Nasdaq
(RXST) Long Term Investment Analysis - Stock Traders Daily
Potential Price Increase for RxSight Inc (RXST) After Recent Insider Activity - Knox Daily
Ready to Jump After Recent Trade: RxSight Inc (RXST) - SETE News
This RxSight Insider Reduced Their Stake By 18% - Simply Wall St
RxSight Inc (RXST): A New Perspective - Stocks Register
RxSight director sells $108,618 in common stock - MSN
(RXST) Technical Pivots with Risk Controls - Stock Traders Daily
Shweta Maniar Sells 3,519 Shares of RxSight, Inc. (NASDAQ:RXST) Stock - MarketBeat
RxSight director sells $108,618 in common stock By Investing.com - Investing.com UK
Midday Stock Roundup: FivePoint Holdings Jumps 36% - Orange County Business Journal
rXsight director Corley Jesse Anderson acquires $100,004 in shares - MSN
RxSight, Inc. (NASDAQ:RXST) Position Reduced by Sara Bay Financial - MarketBeat
Insider Buying: RxSight, Inc. (NASDAQ:RXST) Director Buys 1,443 Shares of Stock - MarketBeat
rXsight director Corley Jesse Anderson acquires $100,004 in shares By Investing.com - Investing.com South Africa
RxSight price target lowered to $43 from $66 at Needham - Yahoo Finance
RxSight (NASDAQ:RXST) Stock Price Down 3.9%Here's Why - MarketBeat
RxSight, Inc. (NASDAQ:RXST) Receives $58.13 Average Price Target from Analysts - MarketBeat
RxSight, Inc. (NASDAQ:RXST) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
RxSight Inc (RXST) Shares Down 4.25% on Jan 14 - GuruFocus.com
RxSight, Inc. (NASDAQ:RXST) Shares Bought by JPMorgan Chase & Co. - Defense World
RxSight (NASDAQ:RXST) Price Target Lowered to $35.00 at Stifel Nicolaus - Defense World
RxSight (NASDAQ:RXST) Receives “Buy” Rating from Needham & Company LLC - Defense World
RxSight (NASDAQ:RXST) Price Target Lowered to $40.00 at Wells Fargo & Company - Defense World
Wells Fargo & Company Lowers RxSight (NASDAQ:RXST) Price Target to $40.00 - MarketBeat
Stifel cuts RxSight shares target, cautious on competition and international expansion efforts By Investing.com - Investing.com South Africa
Ron Kurtz: Revolutionizing Cataract Surgery - Orange County Business Journal
RxSight (NASDAQ:RXST) Sees Unusually-High Trading VolumeTime to Buy? - MarketBeat
Stifel cuts RxSight shares target, cautious on competition and international expansion efforts - Investing.com India
Finanzdaten der Rxsight Inc-Aktie (RXST)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.10%
0.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):